EUVIMEDEUVIMED entdecken
BeobachtungsstudieValidierungsstudieOpen Access · CC BY 4.0

Molecular Traces of Gastric Cancer in Saliva: From Tissue Signatures to Salivary SLC5A5 as a Potential Biomarker

Catarina Lopes, Andreia Brandão iD, Dimitris Vavoulis, Sofia Paulino, João Costa, Inês Marques de Sá, Sara Archer, Ricardo Küttner-Magalhães, Ricardo Marcos-Pinto, Diogo Libânio, Mário Dinis-Ribeiro, Carina Pereira

United European Gastroenterology Journal · 2026-05 · 14 (4)

DOI: 10.1002/ueg2.70221 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift United European Gastroenterology Journal, online erschienen am 23.05.2026. Verfasst von Catarina Lopes und 11 weiteren Autor:innen. Beteiligte Einrichtung: Precancerous Lesions and Early Cancer Management Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Group), Portuguese Oncol…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Saliva, Biomarkers, Tumor, Neoplasms, Second Primary. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia, HORIZON EUROPE Framework Program, UK Research and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early detection of gastric cancer (GC) and reliable risk stratification for metachronous gastric lesions (MGLs) remain societal and clinical challenges, particularly in intermediate risk populations. Non‐invasive approaches such as saliva‐based biomarkers could complement current strategies. The aim of this study was to identify and validate a tissue‐based gene expression signature for early gastric lesions, explore its potential for MGL prediction, and assess its detectability in saliva.

Methods

Three studies were conducted: (1) a retrospective case control study to identify (RNA sequencing with machine learning) and validate (reverse transcription [RT] quantitative polymerase chain reaction [qPCR]) a gene expression signature for early gastric cancer using formalin‐fixed paraffin‐embedded (FFPE) samples, (2) a retrospective longitudinal study evaluating the ability of the signature to stratify MGL risk, and (3) a prospective study testing the signature in saliva using droplet digital (dd)PCR in patients with gastric lesions and endoscopy‐confirmed controls.

Results

A six‐gene tissue‐based expression signature ( ADAMTSL1, CCNA2, HSP90AB1, HSPD1, PSAPL1, and SLC5A5 ) robustly discriminated early gastric lesions from non‐tumor mucosa (area under the curve (AUC) = 0.96 and 95% confidence interval [CI]: 0.94–0.99). Models tailored for MGL prediction, incorporating clinical variables, achieved moderate performance (AUC = 0.74 and 95% CI: 0.59–0.88). In saliva, only the SLC5A5 gene showed consistent dysregulation. When combined with age and sex, the model reached an AUC of 0.78 (95% CI: 0.69–0.88) for the non‐invasive detection of early GC, with a positive predictive value of 0.69 and negative predictive value of 0.81.

Conclusion

This study presents a validated tissue‐based gene signature for early GC detection and exploratory MGL risk stratification. Salivary SLC5A5 shows potential as a non‐invasive biomarker, though its utility requires further validation in dedicated saliva‐based studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsSalivaBiomarkers, TumorNeoplasms, Second PrimarySodium-Iodide SymportersHumansEarly Detection of CancerRetrospective StudiesCase-Control StudiesSequence Analysis, RNAMachine LearningReverse Transcriptase Polymerase Chain ReactionLongitudinal StudiesRisk AssessmentArea Under CurvePredictive Value of TestsReproducibility of ResultsMaleFemaleAdultMiddle AgedAgedAged, 80 and overGene Expression ProfilingGastric Mucosa

Stichwörter der Autor:innen

biomarkersgastric lesionsliquid biopsypersonalized medicine

Substanzen

Biomarkers, TumorSLC5A5 protein, humanSodium-Iodide Symporters

Autor:innen und Institutionen

  • Precancerous Lesions and Early Cancer Management Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Group), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center R…
  • Center for Health Technology and Services Research (CINTESIS@RISE), University of Porto, Porto, Portugal.
  • ICBAS-School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.
  • Cancer Genetics Group, Research Center of IPO Porto (CI-IPOP)/CI-IPOP@RISE (Health Research Group), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC), Porto,…
  • Department of Oncology, Oxford Molecular Diagnostic Center, University of Oxford, Oxford, UK.
  • Biomedical Research Center, The Wellcome Center for Human Genetics, University of Oxford, Oxford, UK.

ORCID-Profile: Andreia Brandão

Förderung

  • Fundação para a Ciência e a Tecnologia
  • HORIZON EUROPE Framework Program
  • UK Research and Innovation
  • HORIZON EUROPE Framework Programme

Zitieren

APA

Lopes, C., Brandão, A., Vavoulis, D., Paulino, S., Costa, J., de Sá, I. M., Archer, S., Küttner-Magalhães, R., Marcos-Pinto, R., Libânio, D., Dinis-Ribeiro, M., & Pereira, C. (2026). Molecular Traces of Gastric Cancer in Saliva: From Tissue Signatures to Salivary SLC5A5 as a Potential Biomarker. United European Gastroenterology Journal, 14(4). https://doi.org/10.1002/ueg2.70221

Vancouver

Lopes C, Brandão A, Vavoulis D, Paulino S, Costa J, de Sá IM, et al. Molecular Traces of Gastric Cancer in Saliva: From Tissue Signatures to Salivary SLC5A5 as a Potential Biomarker. United European Gastroenterology Journal. 2026;14(4). doi:10.1002/ueg2.70221

BibTeX
@article{Lopes2026,
  author = {Lopes, Catarina and Brandão, Andreia and Vavoulis, Dimitris and Paulino, Sofia and Costa, João and de Sá, Inês Marques and Archer, Sara and Küttner-Magalhães, Ricardo and Marcos-Pinto, Ricardo and Libânio, Diogo and Dinis-Ribeiro, Mário and Pereira, Carina},
  title = {Molecular Traces of Gastric Cancer in Saliva: From Tissue Signatures to Salivary SLC5A5 as a Potential Biomarker},
  journal = {United European Gastroenterology Journal},
  year = {2026},
  volume = {14},
  number = {4},
  doi = {10.1002/ueg2.70221}
}
Kostenlos starten →